n Cardiovascular Journal of South Africa - Benefit of clopidogrel in recent myocardial infarction trials : drug trends in cardiology
|Article Title||Benefit of clopidogrel in recent myocardial infarction trials : drug trends in cardiology|
|© Publisher:||Clinics Cardive Publishing|
|Journal||Cardiovascular Journal of South Africa|
|Publication Date||May 2005|
|Pages||182 - 183|
Extracted from text ... Professor Michel Bertrand, visiting South Africa soon after the American College of Cardiology 54th Annual Con gress meeting, focused on the importance of achieving reperfusion as early as possible in the management of acute coronary syndromes. 'In my view, substantiated by recent trials, therapy of aspirin and clopidogrel (300 mg) should be started in the ambulance, preferably within 90 minutes of the event. This simple solution will soon be part of all international guidelines', Prof. Bertrand noted. The two trials announced at the ACC Congress involved 50 000 patients with ST-segment elevation myocardial in farction (STEMI). Together they showed convincing evidence ..
Article metrics loading...